Being tested
BTK inhibition (B cells and microglia): slow disability worsening in primary progressive MS
primary progressive MS · BTK inhibition (B cells and microglia)
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 3
- Running now
- 2
- Controlled phase 2/3 trials
- 2
- People in controlled trials
- 1472
No controlled trial has reported a result yet.
Other linked trials: 3
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 3
These linked trials do not set the status.
- ZB020-03-001Ongoing
Phase 3 · 2026 · Placebo-controlled
- FENtrepidOngoing
Phase 3 · 2020 · Compared with ocrelizumab
- PERSEUSResult in a paper, not read yet
Phase 3 · 2020 · Placebo-controlled
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Being tested
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error